Fate Therapeutics
FATE
#7652
Rank
C$0.36 B
Marketcap
$3.19
Share price
10.63%
Change (1 day)
-0.88%
Change (1 year)

Earnings for Fate Therapeutics (FATE)

Earnings in 2024 (TTM): -C$0.27 Billion

According to Fate Therapeutics 's latest financial reports the company's current earnings are C$12.31 Million. In 2023 the company made an earning of -C$0.27 Billion, an increase over its 2022 earnings that were of -C$0.43 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Fate Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.27 Billion-0.45%
2023 -C$0.27 Billion-38.22%
2022 -C$0.43 Billion45.36%
2021 -C$0.3 Billion43.54%
2020 -C$0.21 Billion53.32%
2019 -C$0.14 Billion48.53%
2018 -C$90.47 Million55.7%
2017 -C$58.11 Million30.98%
2016 -C$44.36 Million14.59%
2015 -C$38.72 Million9.62%
2014 -C$35.32 Million14.83%
2013 -C$30.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$86.72 M-131.83%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.33 B-955.73%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.69 Billion 152.71%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.36 Billion 29.13%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.91 B-435.90%๐Ÿ‡บ๐Ÿ‡ธ USA